Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Artificial Intelligence HeartBot II in Increasing Awareness and Knowledge of Heart Attack in Women: Study Protocol for a Randomized Controlled Trial With a Waitlist Control

NCT07416734 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07416734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Artificial Intelligence HeartBot II in Increasing Awareness and Knowledge of Heart Attack in Women: Study Protocol for a Randomized Controlled Trial With a Waitlist Control
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
June 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

participants must be women aged 25 years or older, participants should have no self-reported history of heart disease or stroke, participants should have no terminal illness or diagnosed cognitive impairment, including alzheimer's disease, participants should not be a healthcare professionals or healthcare trainees, participants should not be employed in the healthcare field, participants should possess a smartphone with an active data plan or access to wi-fi, participants should reside in the united states and be a university of california, san francisco health patient